Aptevo Therapeutics (APVO) Inventory Average (2016 - 2019)
Historic Inventory Average for Aptevo Therapeutics (APVO) over the last 4 years, with Q4 2019 value amounting to $6.8 million.
- Aptevo Therapeutics' Inventory Average rose 13672.23% to $6.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $6.8 million, marking a year-over-year increase of 13672.23%. This contributed to the annual value of $4.0 million for FY2019, which is 6664.56% up from last year.
- Latest data reveals that Aptevo Therapeutics reported Inventory Average of $6.8 million as of Q4 2019, which was up 13672.23% from $7.2 million recorded in Q3 2019.
- Over the past 5 years, Aptevo Therapeutics' Inventory Average peaked at $15.9 million during Q3 2016, and registered a low of $1.1 million during Q4 2017.
- For the 4-year period, Aptevo Therapeutics' Inventory Average averaged around $5.2 million, with its median value being $4.4 million (2017).
- As far as peak fluctuations go, Aptevo Therapeutics' Inventory Average tumbled by 8117.99% in 2017, and later skyrocketed by 16587.54% in 2019.
- Over the past 4 years, Aptevo Therapeutics' Inventory Average (Quarter) stood at $6.0 million in 2016, then plummeted by 81.18% to $1.1 million in 2017, then skyrocketed by 154.04% to $2.9 million in 2018, then soared by 136.72% to $6.8 million in 2019.
- Its Inventory Average stands at $6.8 million for Q4 2019, versus $7.2 million for Q3 2019 and $5.7 million for Q2 2019.